Self-rated health: inequalities and potential determinants EC Alexopoulos, M Geitona International journal of environmental research and public health 6 (9 …, 2009 | 110 | 2009 |
Generic medicines: Greek physicians’ perceptions and prescribing practices V Tsiantou, D Zavras, H Kousoulakou, M Geitona, J Kyriopoulos Journal of clinical pharmacy and therapeutics 34 (5), 547-554, 2009 | 96 | 2009 |
Determinants of healthcare utilization in Greece: implications for decision-making M Geitona, D Zavras, J Kyriopoulos The European journal of general practice 13 (3), 144-150, 2007 | 93 | 2007 |
A supply side investigation of medical tourism and ICT use in Greece I Sarantopoulos, K Vicky, M Geitona Procedia-Social and Behavioral Sciences 148, 370-377, 2014 | 70 | 2014 |
The cost of COPD exacerbations: a university hospital–based study in Greece M Geitona, M Hatzikou, P Steiropoulos, EC Alexopoulos, D Bouros Respiratory medicine 105 (3), 402-409, 2011 | 69 | 2011 |
Health status and access to health services of female prisoners in Greece: a cross-sectional survey M Geitona, SO Milioni BMC health services research 16, 1-8, 2016 | 54 | 2016 |
Managers’ perceptions and opinions towards corporate social responsibility (CSR) in Greece P Leonidas, G Mary, P Theofilos, T Amalia Procedia Economics and Finance 1, 311-320, 2012 | 44 | 2012 |
Generics market in Greece: the pharmaceutical industry's beliefs M Geitona, D Zavras, M Hatzikou, J Kyriopoulos Health Policy 79 (1), 35-48, 2006 | 42 | 2006 |
Antibiotic resistance and irrational prescribing in paediatric clinics in Greece A Toska, M Geitona British Journal of Nursing 24 (1), 28-33, 2015 | 36 | 2015 |
Medication use and patient satisfaction: a population-based survey M Geitona, J Kyriopoulos, D Zavras, T Theodoratou, EC Alexopoulos Family practice 25 (5), 362-369, 2008 | 35 | 2008 |
A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives TI Verhoef, WK Redekop, J Darba, M Geitona, DA Hughes, U Siebert, ... Pharmacogenomics 11 (7), 989-1002, 2010 | 29 | 2010 |
The effects of unemployment and economic distress on depression symptoms D Latsou, M Geitona Materia socio-medica 30 (3), 180, 2018 | 27 | 2018 |
The annual direct costs of stable COPD in Greece E Stafyla, M Geitona, T Kerenidi, A Economou, Z Daniil, KI Gourgoulianis International Journal of Chronic Obstructive Pulmonary Disease, 309-315, 2018 | 27 | 2018 |
Cost estimation of patients admitted to the intensive care unit: a case study of the Teaching University Hospital of Thessaly M Geitona, L Androutsou, D Theodoratou Journal of medical economics 13 (2), 179-184, 2010 | 26 | 2010 |
The economic burden of treating neonates in Intensive Care Units (ICUs) in Greece M Geitona, M Hatzikou, Z Hatzistamatiou, A Anastasiadou, ... Cost effectiveness and resource allocation 5, 1-7, 2007 | 24 | 2007 |
Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs TI Verhoef, WK Redekop, RMF Van Schie, S Bayat, AK Daly, M Geitona, ... Pharmacogenomics 13 (12), 1405-1417, 2012 | 23 | 2012 |
Professional quality of life and occupational stress in healthcare professionals during the COVID-19 pandemic in Greece D Latsou, FM Bolosi, L Androutsou, M Geitona Health Services Insights 15, 11786329221096042, 2022 | 22 | 2022 |
The impact of new antiretroic therapeutic schemes on the cost for AIDS treatment in Greece JE Kyriopoulos, MA Geitona, VA Paparizos, KK Kyriakis, CA Botsi, ... Journal of Medical Systems 25, 73-80, 2001 | 22 | 2001 |
Health Systems’ challenges and responses for recovery in the pre and post COVID-19 era L Androutsou, D Latsou, M Geitona Journal of Service Science and Management 14 (4), 444-460, 2021 | 17 | 2021 |
Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries M Kamusheva, M Manova, AT Savova, GI Petrova, K Mitov, A Harsányi, ... Frontiers in pharmacology 9, 795, 2018 | 17 | 2018 |